ArticleThe Journal of clinical investigation2021

Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.

Stephen P Persaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.